Document Classification

Section Type: METHODS

Text: In a 24-week, randomized, double-blind, placebo-controlled, parallel-group study, 1, 091 patients with type 2 diabetes and A1C 7. 5-11 % were randomized to one of six daily treatments : sitagliptin 100 mg/metformin 1, 000 mg (S100/M1000 group), sitagliptin 100 mg/metformin 2, 000 mg (S100/M2000 group), metformin 1, 000 mg (M1000 group), metformin 2, 000 mg (M2000 group) (all as divided doses administered twice daily [b. i. d.]), sitagliptin 100 mg q. d. (S100 group), or placebo.